Resources

This fact sheet provides COVID-19 vaccination information for in-home and community aged care workers.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for monkeypox.

This framework is for Aged Care Assessment Teams (ACAT). It informs and supports their decision making when recommending Home Care Package levels.

Learn about the clinical pathway that supports the National Cervical Screening Program and the guidelines for pathology testing of cervical and vaginal samples.

The Australian Technical Advisory Group on Immunisation (ATAGI) have developed recommendations on the use of additional (booster) doses of COVID-19 vaccine.

A quick reference guide for healthcare providers about the option of self-collection for cervical screening. It includes information on possible test results and follow-up requirements.

A quick reference guide for healthcare providers about the option of clinician-collection for cervical screening. It includes information on possible test results and follow-up requirements.

This table shows the guidelines for pathology testing of cervical and vaginal samples.

This Communicable Diseases Genomics Network (CDGN), Public Health Laboratory Network (PHLN) and Communicable Diseases Network Australia (CDNA) document contains a sampling strategy for SARS-CoV-2 genomic surveillance.

Information about reporting by residential aged care providers of COVID-19 workforce vaccinations, including what information aged care facilities will collect and report, and why a new reporting tool is being used.

Information for workers about the booster doses including eligibility, when doses are recommended and the type of vaccine used.

These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Gaucher disease.

Treating physicians use this application form to apply for a patient to access LSDP medication for Gaucher disease for the first time, or after a break.

This statement describes how the Department of Health recovers the costs of administering the National Joint Replacement Registry.

This statement describes how the Department of Health recovers the costs of administering the Prostheses List.

This guide was originally created and published by the Council of Australian Governments (COAG) Health Council on 2 August 2018. It outlines food and drink categories that are not recommended for promotion to children in government settings.